Association between head and neck cancer and microsomal epoxide hydrolase genotypes

[1]  F. Oesch,et al.  Mammalian Xenobiotic Epoxide Hydrolases , 2002 .

[2]  G. Steventon,et al.  Enzyme Systems that metabolise drugs and other xenobiotics , 2002 .

[3]  S. Garte,et al.  Metabolic susceptibility genes as cancer risk factors: time for a reassessment? , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[4]  A. Olshan,et al.  GSTM1, GSTT1, and the risk of squamous cell carcinoma of the head and neck: a mini-HuGE review. , 2001, American journal of epidemiology.

[5]  P. van’t Veer,et al.  Role of genetic polymorphism of glutathione-S-transferase T1 and microsomal epoxide hydrolase in aflatoxin-associated hepatocellular carcinoma. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[6]  T. Brüning,et al.  Association of CYP1B1 codon 432 mutant allele in head and neck squamous cell cancer is reflected by somatic mutations of p53 in tumor tissue. , 2001, Cancer research.

[7]  A. Sekine,et al.  Seventy genetic variations in human microsomal and soluble epoxide hydrolase genes (EPHX1 and EPHX2) in the Japanese population , 2001, Journal of Human Genetics.

[8]  D. Christiani,et al.  The interaction between microsomal epoxide hydrolase polymorphisms and cumulative cigarette smoking in different histological subtypes of lung cancer. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[9]  D. Levy,et al.  A case-control study of microsomal epoxide hydrolase, smoking, meat consumption, glutathione S-transferase M3, and risk of colorectal adenomas. , 2001, Cancer research.

[10]  S. Z. Abdel‐Rahman,et al.  Human sensitivity to 1,3-butadiene: role of microsomal epoxide hydrolase polymorphisms. , 2001, Carcinogenesis.

[11]  V. Hosagrahara,et al.  Epoxide hydrolase--polymorphism and role in toxicology. , 2000, Toxicology letters.

[12]  P. Dayer,et al.  High-activity microsomal epoxide hydrolase genotypes and the risk of oral, pharynx, and larynx cancers. , 2000, Cancer research.

[13]  P. Dayer,et al.  Association between lung cancer and microsomal epoxide hydrolase genotypes. , 1998, Cancer research.

[14]  C. J. Omiecinski,et al.  Human hepatic microsomal epoxide hydrolase: comparative analysis of polymorphic expression. , 1997, Archives of Biochemistry and Biophysics.

[15]  F. Oesch,et al.  Gene evolution of epoxide hydrolases and recommended nomenclature. , 1995, DNA and cell biology.

[16]  C. Hassett,et al.  The human microsomal epoxide hydrolase gene (EPHX1): complete nucleotide sequence and structural characterization. , 1994, Genomics.

[17]  D. Grant,et al.  Characterization of the microsomal epoxide hydrolase gene in patients with anticonvulsant adverse drug reactions. , 1994, Pharmacogenetics.

[18]  J. S. Sidhu,et al.  Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants. , 1994, Human molecular genetics.

[19]  P. Beaune,et al.  Principal xenobiotic-metabolizing enzyme systems in human head and neck squamous cell carcinoma. , 1993, Carcinogenesis.

[20]  R. Holubkov,et al.  Human peripheral lymphocytes as indicators of microsomal epoxide hydrolase activity in liver and lung. , 1993, Pharmacogenetics.

[21]  P. Boyle,et al.  Recent advances in the etiology and epidemiology of head and neck cancer. , 1990, Current opinion in oncology.

[22]  F. Guengerich,et al.  Interaction of epoxide hydrolase with itself and other microsomal proteins. , 1982, Archives of biochemistry and biophysics.

[23]  H. Bingham.  Comparative epidemiology of tobacco-related cancers , 1978 .